Nova Meditech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.98 M
- Company Age 26 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.78 M
About Nova Meditech
Nova Meditech Private Limited (NMPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 June 1998 and has a history of 26 years and seven months. Its registered office is in Dakshina Kannada, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.98 M.
The company currently has active open charges totaling ₹1.78 M.
Srinivasa Kakkillaya and Aravinda Kedige serve as directors at the Company.
Company Details
-
Location
Dakshina Kannada, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U65195KA1998PTC023904
-
Company No.
023904
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Jun 1998
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Nova Meditech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aravinda Kedige
|
Managing Director | 30-Jun-1998 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Srinivasa Kakkillaya
|
Director | 30-Jun-1998 | Current |
Financial Performance of Nova Meditech.
Nova Meditech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nova Meditech?
In 2017, Nova Meditech had a promoter holding of 46.94% and a public holding of 53.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.78 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Jun 2004 | Canara Bank | ₹0.38 M | Open |
| 23 Mar 2004 | Canara Bank | ₹0.60 M | Open |
| 29 Aug 1998 | Canara Bank | ₹0.10 M | Open |
| 19 Aug 1998 | Canara Bank | ₹0.71 M | Open |
How Many Employees Work at Nova Meditech?
Unlock and access historical data on people associated with Nova Meditech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nova Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
